Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1943 1
1947 1
1949 1
1950 2
1954 1
1957 1
1958 1
1959 2
1960 4
1961 2
1962 4
1963 6
1964 4
1965 6
1966 5
1967 8
1968 5
1969 9
1970 4
1971 7
1972 5
1973 9
1974 7
1975 3
1976 20
1977 15
1978 8
1979 22
1980 13
1981 2
1982 11
1983 12
1984 14
1985 11
1986 13
1987 10
1988 16
1989 17
1990 7
1991 20
1992 14
1993 20
1994 31
1995 26
1996 36
1997 36
1998 24
1999 40
2000 34
2001 46
2002 49
2003 58
2004 92
2005 105
2006 105
2007 116
2008 136
2009 139
2010 166
2011 162
2012 224
2013 273
2014 286
2015 300
2016 329
2017 348
2018 394
2019 459
2020 545
2021 641
2022 610
2023 602
2024 612
2025 559

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,034 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Han S, Shah RJ. Han S, et al. Among authors: shah rj. Gastrointest Endosc. 2025 Jun;101(6):1278-1279. doi: 10.1016/j.gie.2025.02.018. Gastrointest Endosc. 2025. PMID: 40345754 No abstract available.
Office-Based Laryngology.
Lamm SA, Buckmire RA, Shah RN. Lamm SA, et al. Among authors: shah rn. Otolaryngol Clin North Am. 2025 Aug;58(4):623-640. doi: 10.1016/j.otc.2025.01.012. Epub 2025 May 15. Otolaryngol Clin North Am. 2025. PMID: 40379555 Review.
A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies.
Mosialou I, Ali AM, Labella R, Bisikirska B, Cuesta-Dominguez A, Vgenopoulou P, Reyes I, Rao SM, Wang A, Luo N, Galan-Diez M, Zhao J, Chernak BJ, Bewersdorf JP, Fukasawa K, Su J, Higa J, Adams RA, Corper AL, Pampou S, Woods CM, Fan X, Shah RP, Feldstein J, Liu N, Liang C, Heiblig M, Kornblau S, Garcia-Manero G, Berman E, Jurcic JG, Rabadan R, Raza A, Kousteni S. Mosialou I, et al. Among authors: shah rp. Cancer Cell. 2025 Jun 9;43(6):1007-1024.e13. doi: 10.1016/j.ccell.2025.03.007. Epub 2025 Mar 27. Cancer Cell. 2025. PMID: 40154481
Hermeneutic clinical leadership.
Johnson JA, Shah R, Clarke B, Ahluwalia S. Johnson JA, et al. Among authors: shah r. BMJ Lead. 2025 Jun 9:leader-2024-001209. doi: 10.1136/leader-2024-001209. Online ahead of print. BMJ Lead. 2025. PMID: 40490311 No abstract available.
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
Rousseau B, Patel M, Artz O, Vlachos G, Patel S, Hayatt O, Argilés G, Foote MB, Luo L, Shah R, Mehta S, Rangavajhula K, Stewart CM, Gerber D, Bhattacharya R, Stephens D, Mieles D, Randrian V, Abdelfattah S, Zhang L, Membreno-Berganza N, Lamendola-Essel MF, Piastra-Facon F, Vidal J, Johannet P, Lu S, White JR, Maron SB, Barlas A, Weipert CM, Rosiek E, Zhang T, He B, Monette S, Qu R, Fidele D, Bowker S, Kahn A, Vitiello PP, Germano G, Bardelli A, Mandal R, Ma X, Chan TA, Lu S, Cercek A, Abdel-Wahab O, de Stanchina E, Segal NH, Diaz LA Jr. Rousseau B, et al. Among authors: shah r. Cancer Cell. 2025 Jul 14;43(7):1313-1327.e10. doi: 10.1016/j.ccell.2025.05.010. Epub 2025 Jun 12. Cancer Cell. 2025. PMID: 40513573
A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial.
Felip E, Popat S, Dafni U, Ribi K, Pope A, Cedres S, Shah R, de Marinis F, Cove Smith L, Bernabé R, Früh M, Nackaerts K, Greillier L, Scherz A, Massuti B, Nadal E, Vila Martinez L, Talbot T, Roschitzki-Voser H, Dimopoulou G, Schär S, Ruepp B, Savic S, Peters S, Stahel R; ETOP 13-18 BEAT-meso Collaborators. Felip E, et al. Among authors: shah r. Ann Oncol. 2025 May;36(5):548-560. doi: 10.1016/j.annonc.2024.12.014. Epub 2025 Jan 13. Ann Oncol. 2025. PMID: 39814199 Clinical Trial.
Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older Adults.
Zhou Z, Moran C, Murray AM, Zoungas S, Magnussen C, Chong TT, Shah RC, Sheets KM, Nelson M, Zhu C, Tonkin AM, Talic S, Ernst ME, Orchard SG, McNeil JJ, Wolfe R, Woods RL, Neumann JT, Qiu P, Ryan J. Zhou Z, et al. Among authors: shah rc. Neurology. 2025 Feb 25;104(4):e210247. doi: 10.1212/WNL.0000000000210247. Epub 2025 Jan 29. Neurology. 2025. PMID: 39879572 Free PMC article. Clinical Trial.
Integrated multiomics of pressure overload in the human heart prioritizes targets relevant to heart failure.
Lindman BR, Perry AS, Lance ML, Amancherla K, Kim N, Sheng Q, Lin P, Pfeiffer RD, Farber-Eger E, Fearon WF, Kapadia S, Kumbhani DJ, Gillam L, Mallugari RR, Gupta DK, Miller FJ, Vatterott A, Jackson N, Su YR, Tomasek K, Absi T, Freedman JE, Nayor M, Das S, Wells QS, Dweck MR, Gerszten RE, Gamazon ER, Tucker NR, Shah R, Elmariah S. Lindman BR, et al. Among authors: shah r. Nat Commun. 2025 Jul 26;16(1):6889. doi: 10.1038/s41467-025-62201-2. Nat Commun. 2025. PMID: 40715126 Free PMC article.
7,034 results